HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative experimental study of myocardial protection with crystalloid solutions for heart transplantation.

AbstractBACKGROUND:
There is a growing need to improve myocardial protection, which will lead to better performance of cardiac operations and reduce morbidity and mortality. Therefore, the objective of this study was to compare the efficacy of myocardial protection solution using both intracellular and extracellular crystalloid type regarding the performance of the electrical conduction system, left ventricular contractility and edema, after being subjected to ischemic arrest and reperfusion.
METHODS:
Hearts isolated from male Wistar (n=32) rats were prepared using Langendorff method and randomly divided equally into four groups according the cardioprotective solutions used Krebs-Henseleit-Buffer (KHB), Bretschneider-HTK (HTK), St. Thomas-1 (STH-1) and Celsior (CEL). After stabilization with KHB at 37ºC, baseline values (control) were collected for heart rate (HR), left ventricle systolic pressure (LVSP), maximum first derivate of rise left ventricular pressure (+dP/dt), maximum first derivate of fall left ventricular pressure (-dP/dt) and coronary flow (CF). The hearts were then perfused at 10ºC for 5 min and kept for 2 h in static ischemia at 20ºC in each cardioprotective solution. Data evaluation was done using analysis of variance in completely randomized One-Way ANOVA and Tukey's test for multiple comparisons. The level of statistical significance chosen was P<0.05.
RESULTS:
HR was restored with all the solutions used. The evaluation of left ventricular contractility (LVSP, +dP/ dt and -dP/dt) showed that treatment with CEL solution was better compared to other solutions. When analyzing the CF, the HTK solution showed better protection against edema.
CONCLUSION:
Despite the cardioprotective crystalloid solutions studied are not fully able to suppress the deleterious effects of ischemia and reperfusion in the rat heart, the CEL solution had significantly higher results followed by HTK>KHB>STH-1.
AuthorsMelchior Luiz Lima, Alfredo Inácio Fiorelli, Dalton Valentim Vassallo, Bruno Botelho Pinheiro, Noedir Antonio Groppo Stolf, Otoni Moreira Gomes
JournalRevista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular (Rev Bras Cir Cardiovasc) 2012 Jan-Mar Vol. 27 Issue 1 Pg. 110-6 Brazil
PMID22729308 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bicarbonates
  • Bretschneider cardioplegic solution
  • Cardioplegic Solutions
  • Celsior
  • Crystalloid Solutions
  • Disaccharides
  • Electrolytes
  • Glutamates
  • Isotonic Solutions
  • Krebs-Henseleit solution
  • St. Thomas' Hospital cardioplegic solution
  • Tromethamine
  • Mannitol
  • Sodium Chloride
  • Histidine
  • Procaine
  • Potassium Chloride
  • Glutathione
  • Magnesium
  • Glucose
  • Calcium Chloride
Topics
  • Analysis of Variance
  • Animals
  • Bicarbonates (pharmacology)
  • Calcium Chloride (pharmacology)
  • Cardioplegic Solutions (pharmacology)
  • Crystalloid Solutions
  • Disaccharides (pharmacology)
  • Edema, Cardiac (pathology)
  • Electrolytes (pharmacology)
  • Glucose (pharmacology)
  • Glutamates (pharmacology)
  • Glutathione (pharmacology)
  • Heart Arrest, Induced (methods)
  • Heart Conduction System (drug effects)
  • Heart Transplantation
  • Hemodynamics (drug effects)
  • Histidine (pharmacology)
  • Isotonic Solutions (pharmacology)
  • Magnesium (pharmacology)
  • Male
  • Mannitol (pharmacology)
  • Models, Animal
  • Myocardial Contraction (drug effects)
  • Myocardial Reperfusion Injury (prevention & control)
  • Organ Preservation (methods)
  • Potassium Chloride (pharmacology)
  • Procaine (pharmacology)
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Sodium Chloride (pharmacology)
  • Tromethamine (pharmacology)
  • Ventricular Function, Left (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: